French drugmaker Sanofi and its British peer GSK have started a clinical trial for a proteinbased COVID19 vaccine candidate, as pharmaceutical companies race to develop treatments against the coronavirus pandemic.from Top Business News- News18.com https://ift.tt/34Zs27P
via IFTTT
No comments:
Post a Comment